newsfilter
← Latest News
PR Newswire·

OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer

PENNINGTON, N.J. and SAN DIEGO, April 29, 2022 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the body's immu